Futu News reported on May 24 that the three major indices of Hong Kong stocks fell collectively. As of midday trading, the Hang Seng Index fell 1.27%, the Science Index fell 1.89%, and the National Index fell 1.29%.
By the midday close, Hong Kong stocks had risen 466, down 1,284, and closed down 1,263.
On the sector side, many shares of TechNet declined. Bilibili fell more than 10%, Xiaomi fell more than 3%, JD and Kuaishou fell nearly 3%, Meituan fell more than 2%, Tencent fell more than 1%, Baidu and Ali fell slightly; NetEase rose nearly 2%.
Auto stocks fell, with NIO falling nearly 7%, Xiaopeng Motors and Zero Sports Auto falling more than 3%, Great Wall Motors and BYD shares falling more than 2%, and Geely falling nearly 2%.
Domestic housing stocks fell one after another, with Vanke falling more than 7%, Sunac China and Longhu Group falling more than 5%, Shimao Group falling more than 4%, China Resources Land falling more than 3%, and China's overseas development falling nearly 2%.
Biotech stocks weakened. Kangfang Biotech fell more than 28%, BeiGene Shenzhou fell nearly 6%, Kingsley Biotech fell more than 4%, Pharmaceutical Kangde fell more than 3%, and Pharmaceutical Biotech fell nearly 3%.
Gaming stocks weakened, with Macau International Development falling more than 5%, Wynn Macau falling nearly 4%, Sands China falling nearly 3%, and Aobo Holdings, MGM China, and Galaxy Entertainment falling more than 2%.
Power stocks generally rose. Huadian International and Datang Power rose more than 5%, Huaneng International rose more than 4%, China Electric Power rose more than 3%, and China Resources Electric Power rose nearly 3%.
On the other side, non-ferrous metal stocks such as gold declined, and popular sectors such as catering stocks and photovoltaic stocks fell sharply; oil prices are expected to stop falling and rise again, and three barrels of oil are rising.
In terms of individual stocks,$BILIBILI-W (09626.HK)$It fell by more than 10%. First-quarter revenue increased 12% year over year, and net loss increased 21.4% year over year.
$AKESO (09926.HK)$The drop was more than 28%. According to some sources, Kangfang Biotech's AK112 and EGFR-TKI treated non-small cell lung cancer stage III clinical data in China fell short of expectations.
$CHINA LONGYUAN (00916.HK)$With an increase of more than 5%, Citi indicated that it improved cash flow with less capital expenditure and raised its target price by 31.1%.
$CHINA VANKE (02202.HK)$It fell more than 7%, and was downgraded by Fitch. The company has made frequent financing moves recently.
$MTR CORPORATION (00066.HK)$It fell more than 4%. The agency said that the stock price already reflects potential profit growth, and the company will have large capital expenses in the future.
Top 20 half-day turnover
Edit/Cynthia